Sartorius Stedim Biotech S.A. Stock Wiener Boerse
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time Estimate
Tradegate
05:41:06 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 184.75 EUR | -1.57% |
|
+1.08% | -9.89% |
| 09-08 | Sartorius Stedim Biotech : Barclays remains its Buy rating | ZD |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| Market Cap | 17.9B 20.66B 16.89B 15.33B 28.75B 1,980B 28.96B 202B 77.75B 1,005B 77.6B 75.89B 3,194B | P/E 2026 * |
46.9x | P/E 2027 * | 36.5x |
|---|---|---|---|---|---|
| Enterprise Value | 19.91B 22.98B 18.79B 17.05B 31.98B 2,202B 32.21B 224B 86.47B 1,117B 86.3B 84.4B 3,552B | EV / Sales 2026 * |
6.37x | EV / Sales 2027 * | 5.67x |
| Free-Float |
28.47% | Yield 2026 * |
0.45% | Yield 2027 * | 0.55% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| DIM | Real-time | |
CBOE
| DIMp | Real-time | |
|
CBOE
| 0NK7 | Real-time | |
|
OTC Markets
| SDMHF | Delayed | |
|
Tradegate
| 56S1 | Real-time | |
|
Boerse Muenchen
| 56S1 | Real-time | |
|
Xetra
| 56S1 | Delayed | |
|
Deutsche Boerse AG
| 56S1 | Delayed | |
|
London S.E.
| 0NK7 | Delayed | |
|
Börse Stuttgart
| 56S1 | Delayed | |
|
Borsa Italiana
| 4DIM | End-of-day quote | |
|
Wiener Boerse
| DIM | End-of-day quote |
Last Transcript: Sartorius Stedim Biotech S.A.
| 1 day | -1.57% | ||
| 1 week | +1.08% | ||
| Current month | -5.15% | ||
| 1 month | +1.68% | ||
| 3 months | +6.65% | ||
| 6 months | +16.22% | ||
| Current year | -9.89% |
| 1 week | 185.7 |  | 190.9 |
| 1 month | 179.1 | | 201.6 |
| Current year | 152 | | 222.6 |
| 1 year | 152 | | 222.6 |
| 3 years | 144.4 | | 277.9 |
| 5 years | 144.4 | | 537.6 |
| 10 years | 144.4 | | 548.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.57% | +1.08% | - | - | 20.66B | |
| +1.12% | -4.84% | -22.91% | +0.43% | 178B | |
| +3.12% | -0.39% | -0.24% | +14.45% | 120B | |
| +1.45% | -1.43% | +7.84% | +84.32% | 62.25B | |
| -0.45% | -4.27% | +3.07% | +33.55% | 48.54B | |
| +2.85% | -0.99% | -2.10% | -30.88% | 49.82B | |
| +1.99% | -3.66% | +11.10% | -16.61% | 31.95B | |
| +0.18% | -10.93% | - | - | 28.59B | |
| +2.59% | +4.48% | +40.12% | -10.73% | 25B | |
| -0.88% | -3.61% | -11.03% | +1.86% | 21.59B | |
| Average | +1.04% | -3.58% | +3.23% | +9.55% | 62.9B | |
| Weighted average by Cap. | +1.48% | -3.32% | -4.59% | +11.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.61B 2.95B 2.68B 5.02B 346B 5.06B 35.24B 13.58B 175B 13.55B 13.25B 558B | 3.47B 4B 3.27B 2.97B 5.57B 384B 5.61B 39.09B 15.06B 195B 15.03B 14.7B 619B |
| Net income | 381M 440M 360M 327M 613M 42.19B 617M 4.3B 1.66B 21.4B 1.65B 1.62B 68.04B | 483M 558M 456M 414M 776M 53.44B 782M 5.45B 2.1B 27.11B 2.09B 2.05B 86.19B |
| Net Debt | 2.01B 2.32B 1.9B 1.72B 3.23B 222B 3.25B 22.63B 8.72B 113B 8.7B 8.51B 358B | 1.76B 2.03B 1.66B 1.5B 2.82B 194B 2.84B 19.79B 7.62B 98.51B 7.61B 7.44B 313B |
| Date | Price | Change |
|---|---|---|
| 26-09-09 | €187.70 | -0.69% |
| 26-09-14 | €185.70 | -1.07% |
| 26-09-11 | €187.70 | 0.00% |
| 26-09-10 | €187.70 | -0.69% |
| 26-09-09 | €189.00 | -0.68% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
